Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Access Act Bringing Down Prices In The Philippines

This article was originally published in PharmAsia News

Executive Summary

The Philippines' Universally Accessible Cheaper and Quality Medicine Act of 2008 will bring down local drug prices in the country by promoting a level playing field and free competition, the Philippine Chamber of the Pharmaceutical Industry said at a generics summit in Pasay City

You may also be interested in...



Thai Officials Say Compulsory Licenses Will Not Deter Biotech Business – BIO 2008 Exclusive

SAN DIEGO - Industry furor over Thailand's compulsory license position will not deter multinational companies from investing in the country, according to Thai officials who sat down with PharmAsia News during the BIO 2008 convention in San Diego

Senate Passes Bill on Cheaper Drugs (Phillipines)

The Quality Affordable Medicines Act was among the eight bills passed by the Philippines Senate on Nov. 5. Proposed by Sen. Mar Roxas, the bill will make patent laws more liberal in an effort to reduce prescription drug prices. Additionally, the bill will bolster the Generics Drug Act and widen parallel imports of common medicines by the government. The bill is now being considered by the House. "The more time the House and the Senate have to discuss and reconcile the versions of the bill, the more responsive the bill could be [to] our countrymen's health needs, Roxas notes." (Click here for more

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel